These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 21212755)
21. Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia. Hatzitolios A; Savopoulos C; Lazaraki G; Sidiropoulos I; Haritanti P; Lefkopoulos A; Karagiannopoulou G; Tzioufa V; Dimitrios K Indian J Gastroenterol; 2004; 23(4):131-4. PubMed ID: 15333967 [TBL] [Abstract][Full Text] [Related]
22. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Harrison SA; Torgerson S; Hayashi P; Ward J; Schenker S Am J Gastroenterol; 2003 Nov; 98(11):2485-90. PubMed ID: 14638353 [TBL] [Abstract][Full Text] [Related]
23. Impact of Vitamin E supplementation on lipoprotein peroxidation and composition in Type 1 diabetic patients treated with Atorvastatin. Manuel-Y-Keenoy B; Vinckx M; Vertommen J; Van Gaal L; De Leeuw I Atherosclerosis; 2004 Aug; 175(2):369-76. PubMed ID: 15262194 [TBL] [Abstract][Full Text] [Related]
24. Efficacy of atorvastatin for the treatment of nonalcoholic steatohepatitis with dyslipidemia. Hyogo H; Tazuma S; Arihiro K; Iwamoto K; Nabeshima Y; Inoue M; Ishitobi T; Nonaka M; Chayama K Metabolism; 2008 Dec; 57(12):1711-8. PubMed ID: 19013295 [TBL] [Abstract][Full Text] [Related]
25. A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients. Gómez-Domínguez E; Gisbert JP; Moreno-Monteagudo JA; García-Buey L; Moreno-Otero R Aliment Pharmacol Ther; 2006 Jun; 23(11):1643-7. PubMed ID: 16696815 [TBL] [Abstract][Full Text] [Related]
26. Effect of atorvastatin (10 mg/day) on glucose metabolism in patients with the metabolic syndrome. Huptas S; Geiss HC; Otto C; Parhofer KG Am J Cardiol; 2006 Jul; 98(1):66-9. PubMed ID: 16784923 [TBL] [Abstract][Full Text] [Related]
27. Promising role of ferulic acid, atorvastatin and their combination in ameliorating high fat diet-induced stress in mice. Kesh SB; Sikder K; Manna K; Das DK; Khan A; Das N; Dey S Life Sci; 2013 May; 92(17-19):938-49. PubMed ID: 23567805 [TBL] [Abstract][Full Text] [Related]
28. No effect of combined coenzyme Q10 and selenium supplementation on atorvastatin-induced myopathy. Bogsrud MP; Langslet G; Ose L; Arnesen KE; Sm Stuen MC; Malt UF; Woldseth B; Retterstøl K Scand Cardiovasc J; 2013 Apr; 47(2):80-7. PubMed ID: 23301875 [TBL] [Abstract][Full Text] [Related]
29. Open-label tofacitinib and double-blind atorvastatin in rheumatoid arthritis patients: a randomised study. McInnes IB; Kim HY; Lee SH; Mandel D; Song YW; Connell CA; Luo Z; Brosnan MJ; Zuckerman A; Zwillich SH; Bradley JD Ann Rheum Dis; 2014 Jan; 73(1):124-31. PubMed ID: 23482473 [TBL] [Abstract][Full Text] [Related]
30. Atorvastatin for the treatment of plaque-type psoriasis. Faghihi T; Radfar M; Mehrabian Z; Ehsani AH; Rezaei Hemami M Pharmacotherapy; 2011 Nov; 31(11):1045-50. PubMed ID: 22026392 [TBL] [Abstract][Full Text] [Related]
31. Atorvastatin combining with probucol: a new way to reduce serum uric acid level during perioperative period of interventional procedure. Li H; Li X; Ma H; Wang Y; Fu N; Jin D; Cong H ScientificWorldJournal; 2014; 2014():565367. PubMed ID: 24672331 [TBL] [Abstract][Full Text] [Related]
32. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073 [TBL] [Abstract][Full Text] [Related]
33. STAR VaS--Short Term Atorvastatin Regime for Vasculopathic Subjects: a randomized placebo-controlled trial evaluating perioperative atorvastatin therapy in noncardiac surgery. Neilipovitz DT; Bryson GL; Taljaard M Can J Anaesth; 2012 Jun; 59(6):527-37. PubMed ID: 22528165 [TBL] [Abstract][Full Text] [Related]
34. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial. Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152 [TBL] [Abstract][Full Text] [Related]